Portfolio company
Rewrite Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This deep-tech company develops DNA writing and genome editing tools for biotechnology firms to treat genetic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Replay Therapeutics
This biotech company develops genome writing and delivery platforms to provide genetic medicines for patients with rare skin, eye and haematological diseases.
EditForce
This deep-tech firm develops RNA editing tools and therapies for pharmaceutical, industrial, and agricultural organisations to treat diseases and manipulate genes.
Typewriter Therapeutics
The company develops RNA-based genetic medicines for patients with cancer, autoimmune conditions and rare genetic diseases.
GenEdit
This deep-tech firm develops polymer nanoparticle delivery systems for genetic medicines to treat autoimmune diseases for the pharmaceutical and biotechnology industries.
Insitro
This deep-tech company uses machine learning and genomic data to develop therapeutic drugs for patients with various human diseases.
Immitra Bio
This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.
Replace Therapeutics
The company develops genome editing technology to insert and delete small DNA sequences for biotechnology firms and healthcare researchers.
Seamless Therapeutics
The company develops programmable recombinase-based gene editing therapies for patients with severe genetic diseases through its proprietary technology platform.